|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: APPLIED MOLECULAR EVOLUTION INC, 10-Q, 2000-11-09 |
Next: IRVING CAPITAL CORP, 10QSB, 2000-11-09 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 41,034,689
<SECURITIES> 63,694,047
<RECEIVABLES> 702,639
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 106,677,153
<PP&E> 3,014,114
<DEPRECIATION> 2,393,970
<TOTAL-ASSETS> 108,949,514
<CURRENT-LIABILITIES> 1,424,561
<BONDS> 3,205
0
0
<COMMON> 23,580
<OTHER-SE> 106,592,774
<TOTAL-LIABILITY-AND-EQUITY> 108,949,514
<SALES> 0
<TOTAL-REVENUES> 1,875,721
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 13,338,777
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,290
<INCOME-PRETAX> (9,984,511)
<INCOME-TAX> 0
<INCOME-CONTINUING> (9,984,511)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (9,984,511)
<EPS-BASIC> (2.77)
<EPS-DILUTED> (2.77)
</TABLE>
|
|